[go: up one dir, main page]

AU2016204119A1 - Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias - Google Patents

Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias

Info

Publication number
AU2016204119A1
AU2016204119A1 AU2016204119A AU2016204119A AU2016204119A1 AU 2016204119 A1 AU2016204119 A1 AU 2016204119A1 AU 2016204119 A AU2016204119 A AU 2016204119A AU 2016204119 A AU2016204119 A AU 2016204119A AU 2016204119 A1 AU2016204119 A1 AU 2016204119A1
Authority
AU
Australia
Prior art keywords
isoindol
dione
piperidine
dihydro
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2016204119A
Other versions
AU2016204119B2 (en
Inventor
Jerome B. Zeldis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celgene Corp
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corp filed Critical Celgene Corp
Priority to AU2016204119A priority Critical patent/AU2016204119B2/en
Publication of AU2016204119A1 publication Critical patent/AU2016204119A1/en
Application granted granted Critical
Publication of AU2016204119B2 publication Critical patent/AU2016204119B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method of treating leukemia in a human, which comprises administering to a human in need thereof a therapeutically effective amount of 3-(4-amino-l-oxo-1,3-dihydro-isoindol-2 5 yl)-piperidine-2,6-dione, wherein the leukemia is acute lymphoblastic leukemia, or acute myelogenous leukemia.
AU2016204119A 2005-10-04 2016-06-17 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias Active AU2016204119B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2016204119A AU2016204119B2 (en) 2005-10-04 2016-06-17 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11/244,117 2005-10-04
AU2012200791A AU2012200791B2 (en) 2005-10-04 2012-02-10 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
AU2013251249A AU2013251249B2 (en) 2005-10-04 2013-10-31 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
AU2016204119A AU2016204119B2 (en) 2005-10-04 2016-06-17 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2013251249A Division AU2013251249B2 (en) 2005-10-04 2013-10-31 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias

Publications (2)

Publication Number Publication Date
AU2016204119A1 true AU2016204119A1 (en) 2016-07-14
AU2016204119B2 AU2016204119B2 (en) 2017-12-21

Family

ID=45812538

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2012200791A Active AU2012200791B2 (en) 2005-10-04 2012-02-10 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
AU2013251249A Ceased AU2013251249B2 (en) 2005-10-04 2013-10-31 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
AU2016204119A Active AU2016204119B2 (en) 2005-10-04 2016-06-17 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AU2012200791A Active AU2012200791B2 (en) 2005-10-04 2012-02-10 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
AU2013251249A Ceased AU2013251249B2 (en) 2005-10-04 2013-10-31 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias

Country Status (1)

Country Link
AU (3) AU2012200791B2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7323479B2 (en) * 2002-05-17 2008-01-29 Celgene Corporation Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline

Also Published As

Publication number Publication date
AU2013251249A1 (en) 2013-11-21
AU2016204119B2 (en) 2017-12-21
AU2012200791B2 (en) 2013-08-01
AU2012200791A1 (en) 2012-03-01
AU2013251249B2 (en) 2016-03-17

Similar Documents

Publication Publication Date Title
IL190437A (en) Use of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the preparation of a medicament for treating certain leukemias
ATE381539T1 (en) DIPEPTIDYLPEPTIDASE INHIBITORS FOR THE TREATMENT OF DIABETES
DE60209348D1 (en) DIPEPTIDYLPEPTIDASE INHIBITORS FOR THE TREATMENT OF DIABETES
MA29795B1 (en) INHIBITORS OF DIPEPTIDYL PEPTIDASE FOR THE TREATMENT OF DIABETES
ATE480255T1 (en) COMPOSITIONS AND METHODS FOR CONTROL, PREVENTION AND TREATMENT OF EATING DISORDERS
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
IL178747A0 (en) Methods for treatment of certain cancers using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
GEP20084391B (en) Pyrazoles and methods of making and using the same
ATE416177T1 (en) HETARYLOXY-SUBSTITUTED PHENYLAMINOPYRIMIDINES AS RHO-KINASE INHIBITORS
TW200606144A (en) Crystal of 1,2-dihydropyridine compound
GB0402137D0 (en) Novel compounds
LU92692I2 (en) IBRUTINIB, OR A SALT PHARMACEUTICALLY ACCEPTABLE THERETO
ZA200810113B (en) Method for the treatment and prevention of ocular disorders
TW200633980A (en) Pyridones useful as inhibitors of kinases
GB0402143D0 (en) Novel compounds
WO2005107726A3 (en) Method for the treatment of back pain
MX2008011633A (en) Aminoquinolones as gsk-3 inhibitors.
MX2008008405A (en) Methods for treating cutaneous lupus using aminoisoindoline compounds.
NO20045056L (en) Methods for the treatment of hepatitis
TW200736229A (en) Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
WO2007120726A3 (en) Compositions and methods related to rad51 inactivation in the treatment of neoplastic diseases, and especially cml
MX2024013531A (en) Methods for treating lymphoma
ATE494008T1 (en) USE OF A P38 KINASE INHIBITOR TO TREAT PSYCHIATRIC DISEASES
AU2016204119A1 (en) Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
NO20063326L (en) Combination of (a) N- {5- [4- (4-methyl-piperazinomethyl) -benzoylamide] -2-methylphenyl} -4- (3-pyridyl) -2-pyrimidinamine and (b) at least one hypusination inhibitor and use thereof

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)